# Ernexa Therapeutics Inc.: Form 8-K, filed Nov 1, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2023-11-01
- Accepted by EDGAR: Nov 1, 2023, 08:34 ET
- Period: 2023-10-30
- Accession: 0001140361-23-050682
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036123050682/ef20013697_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036123050682/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036123050682/ef20013697_8k.htm

Filed Nov 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-050682. Last ingested by Listed: Oct 30, 2026, 14:05 ET. No prices; not investment advice.